X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Through collaboration, DreamCIS will be supporting the clinical development with Curi Bio's cutting-edge neuromuscular junction model for advancing Genetox’s Botaone (clostridium botulinum toxin Type A) for Glabellar wrinkles and lateral canthal wrinkles.
Lead Product(s): Clostridium Botulinum Toxin Type A
Therapeutic Area: Dermatology Product Name: Botaone
Highest Development Status: ApprovedProduct Type: Large molecule
Recipient: Dream CIS
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Collaboration February 22, 2024
Details:
Through the acquisition, Curi will gain access to Dana’s AI/ML-based platforms including PhenoLearn™, a deep learning platform for modeling cell and tissue phenotypes; Pulse™, an automated platform for contractility analysis of beating cardiomyocytes; and PhenoTox™.
Lead Product(s): Human iPSC-derived cardiomyocytes
Therapeutic Area: Cardiology/Vascular Diseases Product Name: Undisclosed
Highest Development Status: DiscoveryProduct Type: Cell and Gene therapy
Recipient: Dana Solutions
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Acquisition July 23, 2020
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] 
Market Place
